Gentamycin is one of 41 small molecule programs targeting Sinusitis. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
94 competitors in Sinusitis
Ketek
Asmanex Hfa
Normodyne
Brevibloc
Sporanox
Tobrex
Asmanex
Flovent
Biaxin
Avelox
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details